SCHEMBL21782748

SCHEMBL21782748

CC1CCC2(CC1)CC[S+]([O-])CC2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309070 0.79 KDM4E (0.32) KDM4E
SCHEMBL3021931 0.76
SCHEMBL679645 0.73
SCHEMBL24456477 0.73
SCHEMBL20627354 0.71 APOBEC3A (0.30)
SCHEMBL3013631 0.71
SCHEMBL5565339 0.69 ACHE (0.30)
SCHEMBL10485237 0.68 KDM4E (0.30) KDM4E
SCHEMBL24066446 0.67
SCHEMBL23603998 0.67 TSHR (0.33) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3617204-A1 INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION Nanjing Transthera Biosciences Co. Ltd. (CN) 2020-03-04 EP disclosed